Figure 1From: The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survivalDistribution of anti-p53 antibodies according to treatment and the number of investigated serum samples are defined in the figure textBack to article page